Literature DB >> 10809907

Effect of preoperative prophylaxis with filgrastim in cancer neck dissection.

C Wenisch1, T Werkgartner, H Sailer, S Patruta, R Krause, F Daxboeck, B Parschalk.   

Abstract

BACKGROUND: Cancer surgery is known to lead to a deterioration in host defence mechanisms and an increase in susceptibility to infection after operation. Filgrastim enhances important antimicrobial functions of neutrophils including chemotaxis, phagocytosis and oxidative killing mechanisms.
METHODS: The effects of additional (all patients received perioperative 3 ' 25 mg kg-1 cefotiam and 1 ' 20 mg kg-1 metronidazole) preoperative prophylaxis with filgrastim (5 microg kg-1 12 h prior to surgery plus 5 microg kg-1 0 h prior to surgery) on neutrophil phagocytosis and reactive oxygen radical production and postoperative infections in 24 patients undergoing cancer neck dissection were studied. Phagocytic capacity was assessed by measuring the uptake of fluorescein isothiocyanate-labelled Escherichia coli and Staphylococcus aureus by flow cytometry. Reactive oxygen generation after phagocytosis was estimated by determining the amount of dihydrorhodamine 123 converted to rhodamine 123, intracellularly.
RESULTS: In the filgrastim-treated patients a higher neutrophil phagocytic capacity was seen intraoperatively, and 1-5 days postoperative, but not prior to surgery. Reactive oxygen radical production was significantly higher in filgrastim-treated patients prior to surgery, intraoperative and postoperative (1-5 days). 2/12 (17%) patients had postoperative infections in the filgrastim group and 9/12 (75%) patients had infections in the placebo group (P < 0.001). In particular, wound infections were recorded more often in the placebo group (1/12 vs. 6/12; P = 0.004).
CONCLUSION: We conclude that filgrastim enhances perioperative neutrophil function and could be useful in the prophylaxis of postoperative wound infections in patients undergoing cancer neck dissection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10809907     DOI: 10.1046/j.1365-2362.2000.00643.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  4 in total

Review 1.  Colony-stimulating factors for the management of neutropenia in cancer patients.

Authors:  David C Dale
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  Effects of exogenous recombinant human granulocyte colony-stimulating factor (filgrastim, rhG-CSF) on neutrophils of critically ill patients with systemic inflammatory response syndrome depend on endogenous G-CSF plasma concentrations on admission.

Authors:  Manfred Weiss; Sami Voglic; Britt Harms-Schirra; Ingrid Lorenz; Britta Lasch; Kristoffel Dumon; Wilhelm Gross-Weege; Elisabeth Marion Schneider
Journal:  Intensive Care Med       Date:  2003-04-08       Impact factor: 17.440

3.  Radioprotective effects of oral 17-dimethylaminoethylamino-17-demethoxygeldanamycin in mice: bone marrow and small intestine.

Authors:  Xinyue Lu; Dilber Nurmemet; David L Bolduc; Thomas B Elliott; Juliann G Kiang
Journal:  Cell Biosci       Date:  2013-09-16       Impact factor: 7.133

4.  Prognostic role of neutrophil-to-lymphocyte ratio to laryngeal squamous cell carcinoma: a meta-analysis.

Authors:  Yahui Zhao; Jiangbo Qin; Zhaofeng Qiu; Jianzhou Guo; Wei Chang
Journal:  Braz J Otorhinolaryngol       Date:  2020-11-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.